Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Archives of Internal Medicine

• Publication date

  2002-12-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.162.22.2621PMID 12456235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

  2001cited by this paper
• Stavudine Versus Zidovudine and the Development of Lipodystrophy

  2001cited by this paper
• Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV‐Hepatitis C Virus‐Coinfected Patients Undergoing Antiretroviral Therapy

  2001cited by this paper
• Stavudine versus zidovudine and the development of lipodystrophy.

  2001cited by this paper
• Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

  2001cited by this paper
• Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients.

  2000cited by this paper
• Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection

  2000cited by this paper
• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

  2000cited by this paper
• Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

  2000cited by this paper
• Adverse effects of antiretroviral therapy.

  2000cited by this paper
• A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

  1999cited by this paper
• Fat distribution and metabolic changes in patients with HIV infection.

  1999cited by this paper
• Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.

  1999cited by this paper
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

  1998cited by this paper
• The effect of protease inhibitors on weight and body composition in HIV‐infected patients

  1998cited by this paper
• Potential factors affecting adherence with HIV therapy

  1997cited by this paper

• Effectiveness of self-managed home and community exercise interventions in improving physical activity, body adiposity and related health indices in adults living with HIV: a protocol for a systematic review

  2022cites this paper
• Metabolic and Skeletal Complications of HIV Infection

  2017cites this paper
• HIV Infection and Diabetes

  2016cites this paper
• DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME

  2015cites this paper
• Metabolic complications of antiretroviral therapy (ART) in a South African black population..

  2015cites this paper
• Nutritional State Impact on the Liver Detoxification Function in Patients Infected by HIV under Antiretroviral Drugs at the Bertoua Day Hospital of Cameroon

  2015cites this paper
• Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome

  2015cites this paper
• An update on the pharmacological strategies in the treatment of HIV-1-associated adipose redistribution syndromes

  2014cites this paper
• BIOCHEMICAL CHANGES HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS BEFORE AND AFTER ANTIRETROVIRAL THERAPY

  2014cites this paper
• Immunohistochemical analysis of the expression of TNF-alpha, TGF-beta, and caspase-3 in subcutaneous tissue of patients with HIV lipodystrophy syndrome.

  2014cites this paper
• Human immunodeficiency virus (HIV) associated lipodystrophy: The prevalence, severity and phenotypes in patients on highly active anti-retroviral therapy (HAART) in Kenya

  2013cites this paper
• Psychopharmacological treatments in HIV patients under antiretroviral therapy.

  2012cites this paper
• Dyslipidemia in Patients with Lipodystrophy in the Use of Antiretroviral Therapy

  2012cites this paper
• Potential benefits of carnitine in HIV-positive patients

  2012cites this paper
• Nutrition and the HIV-associated lipodystrophy syndrome

  2012cites this paper
• Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy

  2012cites this paper
• Evaluation of serum level of carnitine in HIV-positive individuals and its possible explanatory factors

  2012cites this paper
• Antiretroviral molecules and cardiovascular diseases.

  2012cites this paper
• Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

  2012cites this paper
• Fat Distribution in Men With HIV Infection From the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)

  2011cites this paper
• Esthetic Self-Perception of HIV/AIDS Patients under Antiretroviral Therapy Suffering from Lipodystrophic Syndrome and its Influence on the Quality of Life in a City of the Brazilian Northeast

  2011cites this paper
• A Comparison of Sonographic Assessments and Clinical Questionnaire in the Diagnosis of HIV-Associated Lipodystrophy

  2011cites this paper
• Bodies in Mutation: Understanding Lipodystrophy Among Women Living With HIV/AIDS

  2011cites this paper
• Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial.

  2011cites this paper
• Disorders of fat partitioning in treated HIV-infection.

  2011cites this paper
• From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir

  2011cites this paper
• HIV-associated lipodystrophy: from fat injury to premature aging.

  2010cites this paper
• Longitudinal study of body composition of 101 HIV men with lipodystrophy: dual-energy X-ray criteria for lipodystrophy evolution.

  2010cites this paper
• HIV Infection and Diabetes

  2010cites this paper
• Disorders of body fat distribution in HIV-1-infected patients.

  2009cites this paper
• Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.

  2009cites this paper
• Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV‐coinfected patients

  2009cites this paper
• Risk factors for incident diabetes mellitus among HIV‐infected patients receiving combination antiretroviral therapy in Taiwan: a case–control study

  2009cites this paper
• Strategies to limit the metabolic complications of treatment for HIV infection

  2009cites this paper
• Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

  2008cites this paper
• Drug-induced paraparotid fat deposition in patients with HIV: case reports.

  2008cites this paper
• Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.

  2008cites this paper
• Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin

  2008cites this paper
• Sex-specific differences in treatment outcomes for patients with HIV and AIDS

  2008cites this paper
• Atrofia de la grasa facial en los pacientes VIH+. Tratamiento mediante inyección de tejido adiposo autólogo.

  2008cites this paper
• Perioperative Guidelines for Elective Surgery in the Human Immunodeficiency Virus–Positive Patient

  2008cites this paper
• [MRI of intra-abdominal fat and HIV-associated lipodystrophy: a case review].

  2008cites this paper
• Síndrome de lipodistrofia en pacientes con infección por VIH que reciben tratamiento antirretroviral

  2008cites this paper
• Ultrasonographic Measurement of Intra-Abdominal Fat Thickness in HIV-Infected Patients Treated or Not with Antiretroviral Drugs and Its Correlation to Lipid and Glycemic Profiles

  2007cites this paper
• IRM du tissu adipeux abdominal et lipodystrophie VIH, étude cas-témoin

  2007cites this paper
• Antiretroviral Therapies Associated with Lipoatrophy in HIV-Infected Women

  2007cites this paper
• Strategies in the treatment of HIV-1-associated adipose redistribution syndromes

  2007cites this paper
• Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.

  2007cites this paper
• Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan.

  2007cites this paper
• Prevalence of and Risk Factors for Pubic Lipoma Development in HIV-Infected Persons

  2007cites this paper
• Switching to a Protease Inhibitor-Containing, Nucleoside-Sparing Regimen (Lopinavir/Ritonavir Plus Efavirenz) Increases Limb Fat But Raises Serum Lipid Levels: Results of a Prospective Randomized Trial (AIDS Clinical Trial Group 5125s)

  2007cites this paper
• Interactions of adipose and lymphoid tissues

  2007cites this paper
• Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study

  2006cites this paper
• Lipodystrophy: lessons in lipid and energy metabolism

  2006cites this paper
• Fat Distribution in Women With HIV Infection

  2006cites this paper
• Metabolic and skeletal complications of HIV infection: the price of success.

  2006cites this paper
• Guideline Watch: Practice Guideline for the Treatment of Patients With HIV/AIDS

  2006cites this paper
• HIV Infection-Related Cachexia and Lipodystrophy

  2006cites this paper
• The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.

  2006cites this paper
• The HAART-Induced Metabolic Syndrome

  2006cites this paper
• Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women.

  2005influential citation
• Body shape and composition in HIV‐infected women: an urban cohort

  2005cites this paper
• Protease Inhibitor-Induced Diabetic Complications

  2005cites this paper
• Current perspectives on HIV-associated lipodystrophy syndrome.

  2005cites this paper
• British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005)

  2005cites this paper
• Are Specific Antiretrovirals associated with an Increased Risk of Discontinuation due to Toxicities or Patient/Physician Choice in patients with Hepatitis C Virus Coinfection?

  2005cites this paper
• Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV‐infected patients: a retrospective cohort study

  2005cites this paper
• British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

  2005cites this paper
• Insulin Resistance in HIV-Infected Men and Women in the Nutrition for Healthy Living Cohort

  2005cites this paper
• Fat Distribution in Men With HIV Infection

  2005cites this paper
• Long-term efficacy of the surgical treatment of buffalo hump in patients continuing antiretroviral therapy

  2004cites this paper
• Pathophysiology of the HIV-Associated Lipodystrophy Syndrome

  2004cites this paper
• Bilateral enophthalmos as a manifestation of HIV infection‐related lipoatrophy

  2004cites this paper
• HIV lipodystrophy syndrome: a primer.

  2004influential citation
• What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection

  2004cites this paper
• Not Just a Complication , But a Basic Variation

  2004cites this paper
• ANORMALIDADES METABÓLICAS EN PACIENTES CON INFECCIÓN POR VIH

  2004cites this paper
• [Metabolic abnormalities in patients with HIV infection].

  2004cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2004cites this paper
• Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy

  2004cites this paper
• Acetyl‐l‐carnitine for the Treatment of HIV Lipoatrophy

  2004cites this paper
• Pharmacologic Therapy for HIV-Associated Lipodystrophy

  2004cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE

  2004cites this paper
• HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment

  2004cites this paper
• Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.

  2004cites this paper
• 159 Human Immunodeficiency Virus / Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome : Clinical Presentation , Pathophysiology , and Therapeutic Strategies

  2003cites this paper
• Risk factors for lipodystrophy in the CISAI cohort.

  2003cites this paper
• Clinical review 159: Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies.

  2003cites this paper
• Gender Differences in Antiretroviral Drug–Related Adipose Tissue Alterations: Women Are at Higher Risk Than Men and Develop Particular Lipodystrophy Patterns

  2003cites this paper
• Pathogenesis and treatment of lipodystrophy in hiv-infected patients receiving highly active antiretroviral therapy

  2003cites this paper
• Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

  2003cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2003cites this paper
• Correlates of Risk of Adipose Tissue Alterations and Their Modifications over Time in HIV-1-Infected Women Treated with Antiretroviral Therapy

  2002cites this paper